Back
Q2 Holdings, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
71
QTWO
Q2 Holdings, Inc.
Last Price:
$75.50
Seasonality Move:
1.51%
Buy
89
KYMR
Kymera Therapeutics, Inc.
Last Price:
$87.93
Seasonality Move:
10.35%
Buy
71
Q2 Holdings, Inc. (QTWO)
is a Buy
Is Q2 Holdings, Inc. a Buy, Sell or Hold?
-
The current Q2 Holdings, Inc. [QTWO] share price is $75.49. The Score for QTWO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
QTWO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
89
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
QTWO Stock Price Chart
What is Q2 Holdings, Inc.'s stock price today?
-
The Q2 Holdings, Inc. share price today is $75.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QTWO is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $87.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
QTWO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.7 | Buy |
| Relative Strength Index (14 RSI): | 65.77 | Buy |
| Chaikin Money Flow: | 570619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.67 - 73.73) | Buy |
| Bollinger Bands (100): | (65.25 - 81.03) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.53 | Buy |
| Relative Strength Index (14 RSI): | 71.11 | Buy |
| Chaikin Money Flow: | -592960 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.18 - 78.14) | Buy |
| Bollinger Bands (100): | (43.11 - 66.09) | Buy |
QTWO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.48 | Buy |
| 20-day SMA: | 72.15 | Buy |
| 50-day SMA: | 67.27 | Buy |
| 200-day SMA: | 78.72 | Sell |
| 8-day EMA: | 73.76 | Buy |
| 20-day EMA: | 72.06 | Buy |
| 50-day EMA: | 70.98 | Buy |
| 200-day EMA: | 76.57 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.75 | Buy |
| 20-day SMA: | 70.43 | Buy |
| 50-day SMA: | 63.87 | Buy |
| 200-day SMA: | 45.05 | Buy |
| 8-day EMA: | 80.77 | Buy |
| 20-day EMA: | 72.92 | Buy |
| 50-day EMA: | 64.9 | Buy |
| 200-day EMA: | 50.57 | Buy |
Q2 Holdings, Inc. Earnings Growth & QTWO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $0.41 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.
Q2 Holdings, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||